Lymphocytosis and important immunological effects associated with dasatinib therapy in choronic myeloid leukemia (CML) - Área de Salud Badajoz

Ir al contenido principal

Av. de Huelva, 8. 06005 Badajoz

info@areasaludbadajoz.com

info@areasaludbadajoz.com

Guía telefónica
Área de Salud

Inicio Repositorio Lymphocytosis and important immunological effects associated with dasatinib therapy in choronic myeloid leukemia (CML)

2009/03/25-27

Lymphocytosis and important immunological effects associated with dasatinib therapy in choronic myeloid leukemia (CML)

Autores/as:

M.V. López, J. Groiss Buiza, M.S. Cava, M.L. vargas Pérez, P. Gemio Zumalave, F.J. liso Rubio

Servicio:

Farmacia. Hospital Universitario Infanta Cristina. En: 14 congress of the european association of hospital pharmacist.Barcelona.(Póster)

Tipo:

Presentación.

Materia:

linfocitosis-terapia

/images/datos/docencia_e_investigacion/lymphocytosis.pdf